Abstract
Cerebrovascular disease is one of the commonest causes of disability and mortality worldwide. Over the past two decades, a tremendous amount of research has been undertaken into developing effective therapeutic strategies for the treatment of acute stroke. Unfortunately, many neuroprotective agents that have shown successful results in treating animal models of acute stroke have failed to translate into clinical treatments. Only tissue-plasminogen activator (t-PA) is currently licensed for use in the treatment of acute ischaemic stroke. One of the important pathophysiological mechanisms involved during the acute phase of stroke is neuroinflammation. This review article will discuss the molecular aspects of neuroinflammation in acute ischaemic stroke and potential therapeutic strategies as part of translational medicine research.
Keywords: Acute stroke, neuroinflammation, neuroprotection, cytokines, inflammatory mediators, oxidative stress, systemic inflammatory response, translational medicine
Current Molecular Medicine
Title: Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside
Volume: 9 Issue: 3
Author(s): Imtiaz M. Shah, I. Mhairi Macrae and Mario Di Napoli
Affiliation:
Keywords: Acute stroke, neuroinflammation, neuroprotection, cytokines, inflammatory mediators, oxidative stress, systemic inflammatory response, translational medicine
Abstract: Cerebrovascular disease is one of the commonest causes of disability and mortality worldwide. Over the past two decades, a tremendous amount of research has been undertaken into developing effective therapeutic strategies for the treatment of acute stroke. Unfortunately, many neuroprotective agents that have shown successful results in treating animal models of acute stroke have failed to translate into clinical treatments. Only tissue-plasminogen activator (t-PA) is currently licensed for use in the treatment of acute ischaemic stroke. One of the important pathophysiological mechanisms involved during the acute phase of stroke is neuroinflammation. This review article will discuss the molecular aspects of neuroinflammation in acute ischaemic stroke and potential therapeutic strategies as part of translational medicine research.
Export Options
About this article
Cite this article as:
Shah M. Imtiaz, Macrae Mhairi I. and Di Napoli Mario, Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside, Current Molecular Medicine 2009; 9 (3) . https://dx.doi.org/10.2174/156652409787847236
DOI https://dx.doi.org/10.2174/156652409787847236 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Symmetry Plane Detection in Brain Image Analysis: A Survey
Current Medical Imaging Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied
Recent Patents on Anti-Cancer Drug Discovery Clinical Science of Calcium Channel Blocker to Inhibit Hypertensive Vascular Injury
Current Hypertension Reviews Electrocardiogram in Andersen-Tawil Syndrome. New Electrocardiographic Criteria for Diagnosis of Type-1 Andersen-Tawil Syndrome
Current Cardiology Reviews Executive Function and Diabetes Mellitus - A Stone Left Unturned?
Current Diabetes Reviews Cardiovascular Proteomics
Current Proteomics Transient Secondary Hypothyroidism and Thyroid Hormone Replacement Therapy in Pediatric Postoperative Cardiopulmonary Bypass
Current Cardiology Reviews New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Enhancing Endothelial Progenitor Cell Function Through Selective Estrogen Receptor Modulation: A Potential Approach to Cardiovascular Risk Reduction
Cardiovascular & Hematological Agents in Medicinal Chemistry Maternal Stress and Placental Vascular Function and Remodeling
Current Vascular Pharmacology Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment
Current Neuropharmacology Update in Pharmacological Management of Coronary No-Reflow Phenomenon
Cardiovascular & Hematological Agents in Medicinal Chemistry Post-menopausal Osteoporosis and Probiotics
Current Drug Targets Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA
CNS & Neurological Disorders - Drug Targets Wound Healing Effects of Curcumin: A Short Review
Current Pharmaceutical Biotechnology Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease
Current Alzheimer Research Chaperonin GroEL: Structure and Reaction Cycle
Current Protein & Peptide Science Patent Selections
Recent Patents on Cardiovascular Drug Discovery Choroidal Changes in Carotid Stenosis Patients After Stenting Detected by Swept-source Optical Coherence Tomography Angiography
Current Neurovascular Research